Research ArticleArticle
Translational Research in Psoriasis
Joerg Christoph Prinz
The Journal of Rheumatology Supplement November 2015, 93 17-20; DOI: https://doi.org/10.3899/jrheum.150627
Joerg Christoph Prinz
From the Department of Dermatology, Ludwig-Maximilian University of Munich, Munich,
Germany.
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Leonardi CL,
- Kimball AB,
- Papp KA,
- Yeilding N,
- Guzzo C,
- Wang Y,
- et al.
- 14.↵
- Papp KA,
- Langley RG,
- Lebwohl M,
- Krueger GG,
- Szapary P,
- Yeilding N,
- et al.
- 15.↵
- 16.↵
- Langley RG,
- Lebwohl M,
- Krueger GG,
- Szapary PO,
- Wasfi Y,
- Chan D,
- et al.
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Ramiro S,
- Gaujoux-Viala C,
- Nam JL,
- Smolen JS,
- Buch M,
- Gossec L,
- et al.
In this issue
Translational Research in Psoriasis
Joerg Christoph Prinz
The Journal of Rheumatology Supplement Nov 2015, 93 17-20; DOI: 10.3899/jrheum.150627
Jump to section
- Article
- Abstract
- Defining Translational Research
- Psoriasis: from Serendipity to True Translational Research
- The 4 Phases of Translational Research in Psoriasis Drug Development
- Increasing Specificity and Efficacy of Treatment by Precise Interference with Psoriasis Pathogenesis
- Perspectives of Translational Research in Psoriasis
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics
- References
- eLetters